T2DM

Sub-Areas to T2DM:

Risk Factors (0)
Cardiovascular (1)
Neural (1)
Renal (0)
Ophthalmic (0)
Guidelines (0)

(Journal Article): Type 2 Diabetes Mellitus and its Complications: From the Molecular Biology to the Clinical Practice

Malecki MT

IN: Rev Diabetic Stud 2004; 1(1):5-8
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

ABSTRACT: Introduction: Probably the most urgent problem in the field of diabetology, and one of the most important in XXI. century medicine, is an epidemic of type 2 diabetes mellitus. ... Click HERE for details

(Journal Article): A Case of Acquired Generalized Lipodystrophy with Cerebellar Degeneration and Type 2 Diabetes Mellitus

Chao PJ, Tsai JCR, Chang DM, Shin SJ, Lee YJ

IN: Rev Diabetic Stud 2004; 1(4):193-197
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

ABSTRACT: Acquired generalized lipodystrophy (AGL) is a rare disorder of adipose tissue characterized by loss of fat from large regions of the body, occurring after birth. Its etiology remai... Click HERE for details

(Journal Article): Epidemiology and genetics of diabetes mellitus.

Warram JH, Rich SS, Krolewski A

IN: Joslin's diabetes mellitus. 13th edition. Eds. Kahn CR, Weir GC. Pensylvania: Lea & Febiger, Malvern, PE, USA. 1994

Click HERE for details

(Journal Article): Genetic variation in the gene encoding calpain 10 is associated with type 2 diabetes mellitus.

Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE et al

IN: Nat Genet 2000; 26:163-75
Impact Factor(s) of Nat Genet: 25.797 (2005), 24.695 (2004), 26.494 (2003), 26.711 (2002), 29.6 (2001)

Click HERE for details

(Journal Article): Segregation analysis of diabetic nephropathy in Pima Indians.

Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL

IN: Diabetes 2000; 9:1049-1056
Impact Factor(s) of Diabetes: 8.848 (2004), 8.298 (2003), 8.256 (2002), 7.7 (2001)

Click HERE for details

(Journal Article): Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes.

Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC

IN: Diabetes 1998; 47:821-830
Impact Factor(s) of Diabetes: 8.848 (2004), 8.298 (2003), 8.256 (2002), 7.7 (2001)

Click HERE for details

(Journal Article): Epidemiology of late complications of diabetes.

Krolewski AS, Warram JH

IN: Joslin's diabetes mellitus, 13th edition. Eds. Kahn CR, Weir GC. Pensylvania, Lea & Febiger, Malvern, PE, USA 1994;

ABSTRACT: not available Click HERE for details

(Journal Article): Diabetic retinopathy in identical twins.

Leslie RD, Pyke DA

IN: Diabetes 1982; 31:19-21
Impact Factor(s) of Diabetes: 8.848 (2004), 8.298 (2003), 8.256 (2002), 7.7 (2001)

Click HERE for details

(Journal Article): Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus.

Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS

IN: Diabet Med 2000; 17:111-118
Impact Factor(s) of Diabet Med: 2.621 (2004), 2.235 (2003), 2.678 (2001)

Click HERE for details

(Journal Article): Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus.

Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC, El Nahas AM, Plater ME, Shaw J, Boulton AJ, Duff GW, Cox A

IN: Diabet Med 2001; 18:906-914
Impact Factor(s) of Diabet Med: 2.621 (2004), 2.235 (2003), 2.678 (2001)

Click HERE for details

(Journal Article): Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5'-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus.

Ichikawa F, Yamada K, Ishiyama-Shigemoto S, Yuan X, Nonaka K

IN: Diabet Med 1999; 16:744-748
Impact Factor(s) of Diabet Med: 2.621 (2004), 2.235 (2003), 2.678 (2001)

Click HERE for details

(Journal Article): Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.

Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC

IN: Diabetes Care 2003; 26:2410-2415
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)

Click HERE for details

(Journal Article): Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.

Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP

IN: Diabetes Care 2003; 26:2628-2631
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)

Click HERE for details

(Journal Article): Strong Heart Study. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, Howard BV

IN: J Am Coll Cardiol 2002; 40:1984-1990
Impact Factor(s) of J Am Coll Cardiol: 9.133 (2004), 7.599 (2003), 6.278 (2002), 6.374 (2001)

ABSTRACT: not available Click HERE for details

(Journal Article): Haptoglobin phenotype and coronary artery collaterals in diabetic patients.

Hochberg I, Roguin A, Nikolsky E, Chanderashekhar PV, Cohen S, Levy AP

IN: Atherosclerosis 2002; 161:441-446
Impact Factor(s) of Atherosclerosis: 3.796 (2004), 3.603 (2003), 3.333 (2002), 3.469 (2001)

Click HERE for details

(Journal Article): Predictive genetic testing in maturity-onset diabetes of the young (MODY).

Shepherd M, Ellis I, Ahmad AM, Todd PJ, Bowen-Jones D, Mannion G, Ellard S, Sparkes AC, Hattersley AT

IN: Diabet Med 2001; 18:417-21
Impact Factor(s) of Diabet Med: 2.621 (2004), 2.235 (2003), 2.678 (2001)

Click HERE for details

(Journal Article): Genetic cause of hyperglycaemia and response to treatment in diabetes.

Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT

IN: Lancet 2003; 362:1275-1281
Impact Factor(s) of Lancet: 23.407 (2005), 21.713 (2004), 18.316 (2003), 15.397 (2002), 13.251 (2001)

Click HERE for details

(Journal Article): In vivo gene therapy for diabetes mellitus.

Chan L, Fujimiya M, Kojima H

IN: Trends Mol Med 2003; 9:430-435
Impact Factor(s) of Trends Mol Med: 7.497 (2004), 9.848 (2003), 7.162 (2002)

Click HERE for details

Contribute to this subject area!

About DOD | Advertising Information | Support The Project | DOD alert | Become Editor